Real-time ECG Monitoring for Vagus Nerve Stimulation Titration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current vagus nerve stimulation therapies for congestive heart failure lack effective methods to assess and optimize the autonomic response to stimulation intensity, leading to potential side effects and inefficiencies in titration processes.

Innovation Solution

A system and method that includes a processor and ECG signal capture to determine and display heart rate dynamics and ECG responses in real-time, allowing for the assessment of autonomic engagement and adjustment of stimulation intensity during titration, using a device that delivers periodic stimulation signals to the vagus nerve.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If VNS therapy intensity is gradually increased during titration, then therapeutic efficacy is improved, but patient discomfort and side effects increase

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidpatient discomfort and side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system continuously monitors heart rate dynamics and ECG responses during VNS titration and provides real-time feedback to the clinician. This feedback loop allows adjustment of stimulation intensity based on actual physiological response, enabling optimization of therapeutic efficacy while minimizing patient discomfort and side effects.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system dynamically adjusts the titration process by monitoring real-time changes in heart rate variability and ECG morphology. The stimulation intensity can be modified based on observed dynamic responses, allowing flexible optimization of therapy intensity to achieve therapeutic goals while avoiding excessive discomfort.

Inventive Principle:
Principle #15Dynamics

2Reliability

If full therapeutic dose of VNS is delivered immediately, then therapeutic efficacy is maximized, but patient discomfort and side effects increase significantly

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidpatient discomfort
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system implements a structured titration process that begins with sub-therapeutic intensity levels and progressively increases to the full therapeutic dose. This preliminary gradual increase allows the patient's autonomic nervous system to adapt to the stimulation, reducing the risk of excessive discomfort and side effects while maintaining the eventual delivery of full therapeutic efficacy.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system employs periodic stimulation cycles with controlled ON and OFF periods during the titration process. This periodic delivery pattern allows the patient's system to acclimate to the stimulation over time, reducing cumulative discomfort while maintaining therapeutic effectiveness through repeated dosing.

Inventive Principle:
Principle #19Periodic action

3Device complexity

If stimulation intensity is increased without real-time monitoring, then titration process is simpler, but assessment of autonomic response is insufficient

Engineering Contradiction:
Improvetitration process complexityVSAvoidassessment of autonomic response
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The system incorporates real-time monitoring of heart rate dynamics and ECG responses that provides immediate feedback on autonomic engagement. This feedback mechanism enables precise assessment of whether the stimulation intensity is producing the desired physiological effects, allowing for accurate titration decisions despite the added monitoring complexity.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system replaces manual assessment methods with automated electronic monitoring of physiological parameters. Digital sensors continuously track heart rate variability and ECG morphology, substituting mechanical/manual evaluation with electronic measurement and analysis, thereby improving assessment precision while managing complexity through automation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Measurement precision

If real-time monitoring and display of heart rate dynamics is implemented, then assessment of autonomic engagement is improved, but device complexity and cost increase

Engineering Contradiction:
Improveassessment of autonomic engagementVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system utilizes existing ECG monitoring capabilities and standard physiological sensors that can serve multiple functions: monitoring heart rate, detecting arrhythmias, assessing autonomic engagement, and guiding titration. This multi-functionality approach improves assessment precision without proportionally increasing system complexity or cost.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system creates digital representations and visual displays of physiological parameters (heart rate dynamics, ECG waveforms) that replicate the actual physiological state in a simplified visual format. This copying approach enables precise assessment of autonomic engagement through intuitive visual feedback without requiring complex analysis hardware or sophisticated measurement systems.

Inventive Principle:
Principle #26Copying

Data Source

PatentUS11752341B2Display signal to assess autonomic response to vagus nerve stimulation treatment
Publication Date: 2023.09.12 LIVANOVA USA INC
  • US11752341B2 patent drawing
  • US11752341B2 patent drawing
  • US11752341B2 patent drawing

AI summary

An assessment system is provided for vagus nerve stimulation therapy treatment for congestive heart failure in a subject. The assessment system includes a first interface configured to communicate with a device that delivers a stimulation signal to a vagus nerve of the subject, a second interface configured to capture heart electrical activity of the subject in response to the stimulation signal, and a processor and a non-transitory computer readable memory storing instructions that, when executed by the processor, cause the assessment system to determine and display heart rate dynamics and display a digital ECG signal in real-time in response to the stimulation signal.